For instance, in a study that evaluated the effects of Anakinra (interleukin-1 receptor antagonist) in 80 patients with rheumatoid arthritis on coronary and left ventricular function, the patients with higher IL-1B levels presented the highest reduction in GLS after Anakinra administration. The gene discussed is IL1B; the disease is rheumatoid arthritis.